ASCO endorses AUA/ASTRO/SUO guidelines on treatment of localized prostate cancer

We are delighted to note that the American Society of Clinical Oncology (ASCO) has now endorsed 66 of the 68 guidelines issued in April 2017 on the treatment of localized prostate cancer by a joint working group from the American Uriological Association (AUA), the American Society of Radiation Oncology (ASTRO), and the Society for Urologic Oncology (SUO). … READ MORE …

Lancet comments on PBRT in treatment of prostate cancer

On June 5 we had noted that, the day before, the American Society for Radiation Oncology (ASTRO) released its model policy on the use of proton beam radiation therapy (PBRT) and related reimbursement issues. … READ MORE …

ASTRO prostate cancer reports: no. 3

Prostate cancer reports from the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), held in Boston, have kindly been provided by Eyad Abu-Isa, MD, a resident in radiation oncology at the University of Michigan

This year’s scientific sessions concluded on Wednesday with two sessions focused on prostate cancer therapies and long-term outcomes and one afternoon session focused on quality of life outcomes. … READ MORE …